0RGO Stock Overview
DMS Imaging SA engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
DMS Imaging SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.019 |
| 52 Week High | €0.019 |
| 52 Week Low | €0.015 |
| Beta | 0.53 |
| 1 Month Change | 5.56% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RGO | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | 3.8% | 2.0% |
| 1Y | n/a | -23.3% | 4.5% |
Return vs Industry: Insufficient data to determine how 0RGO performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how 0RGO performed against the UK Market.
Price Volatility
| 0RGO volatility | |
|---|---|
| 0RGO Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 8.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0RGO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0RGO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 118 | Frank Hazevoets | www.dms-imaging.com |
DMS Imaging SA engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022.
DMS Imaging SA Fundamentals Summary
| 0RGO fundamental statistics | |
|---|---|
| Market cap | €35.75m |
| Earnings (TTM) | -€878.00k |
| Revenue (TTM) | €39.66m |
0.9x
P/S Ratio-40.7x
P/E RatioIs 0RGO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RGO income statement (TTM) | |
|---|---|
| Revenue | €39.66m |
| Cost of Revenue | €23.02m |
| Gross Profit | €16.64m |
| Other Expenses | €17.52m |
| Earnings | -€878.00k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00059 |
| Gross Margin | 41.96% |
| Net Profit Margin | -2.21% |
| Debt/Equity Ratio | 139.0% |
How did 0RGO perform over the long term?
See historical performance and comparison